- Home
- GOSS vs NBH Comparison
GOSS vs NBH Comparison
Compare GOSS & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- NBH
- Stock Information
- Founded
- GOSS 2015
- NBH 2002
- Country
- GOSS United States
- NBH United States
- Employees
- GOSS N/A
- NBH N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- GOSS Health Care
- NBH Finance
- Exchange
- GOSS Nasdaq
- NBH Nasdaq
- Market Cap
- GOSS 347.8M
- NBH 287.0M
- IPO Year
- GOSS 2019
- NBH N/A
- Fundamental
- Price
- GOSS $1.96
- NBH $9.86
- Analyst Decision
- GOSS Strong Buy
- NBH
- Analyst Count
- GOSS 4
- NBH 0
- Target Price
- GOSS $8.50
- NBH N/A
- AVG Volume (30 Days)
- GOSS 3.2M
- NBH 85.9K
- Earning Date
- GOSS 08-05-2025
- NBH 01-01-0001
- Dividend Yield
- GOSS N/A
- NBH 4.34%
- EPS Growth
- GOSS N/A
- NBH N/A
- EPS
- GOSS N/A
- NBH 0.12
- Revenue
- GOSS $40,237,000.00
- NBH N/A
- Revenue This Year
- GOSS N/A
- NBH N/A
- Revenue Next Year
- GOSS $63.97
- NBH N/A
- P/E Ratio
- GOSS N/A
- NBH $87.04
- Revenue Growth
- GOSS N/A
- NBH N/A
- 52 Week Low
- GOSS $0.66
- NBH $8.75
- 52 Week High
- GOSS $2.23
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- GOSS 58.35
- NBH 50.89
- Support Level
- GOSS $1.67
- NBH $9.79
- Resistance Level
- GOSS $2.00
- NBH $9.96
- Average True Range (ATR)
- GOSS 0.17
- NBH 0.09
- MACD
- GOSS -0.02
- NBH 0.01
- Stochastic Oscillator
- GOSS 52.21
- NBH 47.62
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.